International DSD Symposium Sao Paulo Survey- Feedback Evaluation

7th International DSD Symposium - São Paulo 2019

Dear Delegate, thank you for attending the 7th international DSD meeting in São Paulo. The I-DSD steering committee and the project management group would be grateful if you could complete the following on-line questionnaire which should not take more than 5 minutes of your time.

Thursday 4th - Saturday 6th July 2019
Faculdade de Medicina da Universidade de São Paulo,Brazil

Contact: Jillian.Bryce@glasgow.ac.uk

CPD certificates are issued upon submission of the evaluation form.

Question Title

* 1. Name (optional)

Question Title

* 2. E-mail address (optional)

Email Address

Question Title

* 3. Organisation/Department

Question Title

* 4. Job Title

The Training Workshop was held on Thursday morning 4th July before the start of the symposium. Please complete this section if you attended all or part of this event.

Question Title

* 5. Please rate the value of the individual workstations (1 is the least, 4 is the best)

	1	2	3	4	Did not attend
Using the I-DSD/CAH Registry, Salma Ali & Angela Lucas-Herald (Glasgow)	Using the I-DSD/CAH Registry, Salma Ali & Angela Lucas-Herald (Glasgow) 1	Using the I-DSD/CAH Registry, Salma Ali & Angela Lucas-Herald (Glasgow) 2	Using the I-DSD/CAH Registry, Salma Ali & Angela Lucas-Herald (Glasgow) 3	Using the I-DSD/CAH Registry, Salma Ali & Angela Lucas-Herald (Glasgow) 4	Using the I-DSD/CAH Registry, Salma Ali & Angela Lucas-Herald (Glasgow) Did not attend
Bioinformatics tools, Amit Pandey (Bern)	Bioinformatics tools, Amit Pandey (Bern) 1	Bioinformatics tools, Amit Pandey (Bern) 2	Bioinformatics tools, Amit Pandey (Bern) 3	Bioinformatics tools, Amit Pandey (Bern) 4	Bioinformatics tools, Amit Pandey (Bern) Did not attend
Communication with a new patient, Amy Wisniewski (Oklahoma City)	Communication with a new patient, Amy Wisniewski (Oklahoma City) 1	Communication with a new patient, Amy Wisniewski (Oklahoma City) 2	Communication with a new patient, Amy Wisniewski (Oklahoma City) 3	Communication with a new patient, Amy Wisniewski (Oklahoma City) 4	Communication with a new patient, Amy Wisniewski (Oklahoma City) Did not attend

I-DSD Symposium Day 1
Session 1- Setting the Scene
Chair: Berenice B Mendonca & Faisal Ahmed

Question Title

* 6. Setting the Scene for the session: "Patients experiences introduced by Guilherme Guaragna-Filho" (Porto Alegre, Brazil)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical Value	Clinical Value 1	Clinical Value 2	Clinical Value 3	Clinical Value 4	Clinical Value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Session 2 - The Impact of Collaborators
Chair: Anna Nordenstrom & Ivo Arnold

Question Title

* 7. Impact of European Collaboration - Olaf Hiort (Lubeck, Germany)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 8. Impact of collaboration in North America - David Sandberg (Ann Arbor, USA)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 9. A network for DSD in the Asia & Pacific Region - Reiko Horikawa (Tokyo, Japan)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 10. I-DSD/I-CAH & EuRRECa - a template for the future - Faisal Ahmed (Glasgow, UK)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 11. Future Directions Round Table

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Session 3 - Lecture
Chair: Berenice B. Mendonca

Question Title

* 12. Family-centered, interdisciplinary care: Educating DSD people and their families and loved ones - Amy Wisniewski (Oklahoma City, USA)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

I-DSD Symposium Day 2
Session 4 - Improving Diagnostic Outcomes in DSD
Chair: Ana Latronica & Vincent Harley

Question Title

* 13. The strengths and pitfalls of genetics - Ken McElreavey (Paris, France)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 14. The strengths and pitfalls of biochemistry - Richard Auchus (Ann Arbor, USA)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 15. Combining genetics & biochemistry - Christa Fluck (Bern, Switzerland)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Session 5 - Improving Health Outcomes in Sex Chromosome Disorders
Chair: Amy Wisniewski & Durval Damiani

Question Title

* 16. Turner Syndrome - Theo Sas (Rotterdam, Netherlands)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 17. Klinefelter Syndrome - Claus Gravholt (Aarhus, Denmark)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 18. 45X/46XY - Martine Cools (Ghent, Belgium)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 19. Challenging case discussions in DSD
Presenters: Hedi Claahsen & Berenice Mendonca
Moderators: David Sandberg & Rodolfo Rey

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Session 6 - Congenital Adrenal Hyperplasia
Chair: Christa Fluck & Gil Guerra-Junior

Question Title

* 20. Diagnosis of CAH - Roxana Marino (Buenos, Aires, Argentina)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 21. Controversies in steroid replacement - Tania Bachega (Sao Paulo, Brazil)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 22. Critical outcomes in virilising CAH - Hedi Claahsen (Nijmegen, Netherlands)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

I-DSD Symposium Day 3

I-DSD Symposium Day 3
Session 7 - Improving Surgical Outcomes
Chair: Eduardo Correa Costa &Steven Chernausek

Question Title

* 23. Female Genitoplasty - Maria Helena Sircili (Sau Paulo, Brazil)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 24. Male Genitoplasty - Francisco Tibor Denes (Sau Paulo, Brazil)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 25. Postponing surgery in CAH: Nothing is ever black and white - Ignacio Bergada (Buenos Aires, Argentina)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 26. Auditing outcomes of surgery - Stuart O'Toole (Glasgow, UK)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Session 8 - This house believes that it is time to discard the term 'DSD'
Chair: Berenice B. Mendonca & Faisal Ahmed

Question Title

* 27. For - Eric Vilain (Los Angeles, USA)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Question Title

* 28. Against - Andy Greenfield (Oxford, UK)

	1	2	3	4	Did not attend
Scientific content	Scientific content 1	Scientific content 2	Scientific content 3	Scientific content 4	Scientific content Did not attend
Clinical value	Clinical value 1	Clinical value 2	Clinical value 3	Clinical value 4	Clinical value Did not attend
Likelihood of altering your clinical or research practice	Likelihood of altering your clinical or research practice 1	Likelihood of altering your clinical or research practice 2	Likelihood of altering your clinical or research practice 3	Likelihood of altering your clinical or research practice 4	Likelihood of altering your clinical or research practice Did not attend

Commercial bias

Question Title

* 29. Did all speakers provide their potential conflict of interest declaration with the sponsor(s) as a 2nd slide in their presentation?

1 - Dont' know, 2 - No, 3 - Yes a few, 4 - Yes mostly, 5 - Yes all

	1	2	3	4	5
Please rate as appropriate.	Please rate as appropriate. 1	Please rate as appropriate. 2	Please rate as appropriate. 3	Please rate as appropriate. 4	Please rate as appropriate. 5

Additional comments

Question Title

* 30. Do you agree that the information was overall free of commercial and other bias?

1 - Don't know, 2 - Strongly disagree, 3 - Rather disagree, 4 - Rather agree, 5 - Strongly agree

	1	2	3	4	5
Please rate as appropriate.	Please rate as appropriate. 1	Please rate as appropriate. 2	Please rate as appropriate. 3	Please rate as appropriate. 4	Please rate as appropriate. 5

Additional comments

Social Events and Summary

Question Title

* 31. Social Event

	1	2	3	4	Did not attend
Social Dinner	Social Dinner 1	Social Dinner 2	Social Dinner 3	Social Dinner 4	Social Dinner Did not attend

Question Title

* 32. How did you rate the quality and educational value of the two oral communication sessions?

1 - poor, 5 - excellent

	1	2	3	4	5
Please rate as appropriate.	Please rate as appropriate. 1	Please rate as appropriate. 2	Please rate as appropriate. 3	Please rate as appropriate. 4	Please rate as appropriate. 5

Additional comments

Question Title

* 33. How do you rate the relevance of this Symposium to your need to keep informed about DSD research

1 - no part relevant, 2 - little of relevance, 3 - fairly relevant, 4 - mostly relevant, 5 - highly relevant

	1	2	3	4	5
Please rate as appropriate.	Please rate as appropriate. 1	Please rate as appropriate. 2	Please rate as appropriate. 3	Please rate as appropriate. 4	Please rate as appropriate. 5

additional comments

Question Title

* 34. How did you rate the quality and educational value of the poster session?

1 - poor, 5 - excellent

	1	2	3	4	5
Please rate as appropriate.	Please rate as appropriate. 1	Please rate as appropriate. 2	Please rate as appropriate. 3	Please rate as appropriate. 4	Please rate as appropriate. 5

Additional comments

Question Title

* 35. What was your overall impression of this event?

	Excellent	Good	Satisfactory	Mediocre	Poor
Programme	Programme Excellent	Programme Good	Programme Satisfactory	Programme Mediocre	Programme Poor
Quality of Education	Quality of Education Excellent	Quality of Education Good	Quality of Education Satisfactory	Quality of Education Mediocre	Quality of Education Poor
Organisation	Organisation Excellent	Organisation Good	Organisation Satisfactory	Organisation Mediocre	Organisation Poor
Catering	Catering Excellent	Catering Good	Catering Satisfactory	Catering Mediocre	Catering Poor
Venue	Venue Excellent	Venue Good	Venue Satisfactory	Venue Mediocre	Venue Poor

Question Title

* 1. Name (optional)

Question Title

* 2. E-mail address (optional)

Question Title

* 3. Organisation/Department

Question Title

* 4. Job Title

Question Title

* 5. Please rate the value of the individual workstations (1 is the least, 4 is the best)

Question Title

* 6. Setting the Scene for the session: "Patients experiences introduced by Guilherme Guaragna-Filho" (Porto Alegre, Brazil)

Question Title

* 7. Impact of European Collaboration - Olaf Hiort (Lubeck, Germany)

Question Title

* 8. Impact of collaboration in North America - David Sandberg (Ann Arbor, USA)

Question Title

* 9. A network for DSD in the Asia & Pacific Region - Reiko Horikawa (Tokyo, Japan)

Question Title

* 10. I-DSD/I-CAH & EuRRECa - a template for the future - Faisal Ahmed (Glasgow, UK)

Question Title

* 11. Future Directions Round Table

Question Title

* 12. Family-centered, interdisciplinary care: Educating DSD people and their families and loved ones - Amy Wisniewski (Oklahoma City, USA)

Question Title

* 13. The strengths and pitfalls of genetics - Ken McElreavey (Paris, France)

Question Title

* 14. The strengths and pitfalls of biochemistry - Richard Auchus (Ann Arbor, USA)

Question Title

* 15. Combining genetics & biochemistry - Christa Fluck (Bern, Switzerland)

Question Title

* 16. Turner Syndrome - Theo Sas (Rotterdam, Netherlands)

Question Title

* 17. Klinefelter Syndrome - Claus Gravholt (Aarhus, Denmark)

Question Title

* 18. 45X/46XY - Martine Cools (Ghent, Belgium)

Question Title

* 19. Challenging case discussions in DSDPresenters: Hedi Claahsen & Berenice MendoncaModerators: David Sandberg & Rodolfo Rey

Question Title

* 20. Diagnosis of CAH - Roxana Marino (Buenos, Aires, Argentina)

Question Title

* 21. Controversies in steroid replacement - Tania Bachega (Sao Paulo, Brazil)

Question Title

* 22. Critical outcomes in virilising CAH - Hedi Claahsen (Nijmegen, Netherlands)

Question Title

* 23. Female Genitoplasty - Maria Helena Sircili (Sau Paulo, Brazil)

Question Title

* 24. Male Genitoplasty - Francisco Tibor Denes (Sau Paulo, Brazil)

Question Title

* 25. Postponing surgery in CAH: Nothing is ever black and white - Ignacio Bergada (Buenos Aires, Argentina)

Question Title

* 26. Auditing outcomes of surgery - Stuart O'Toole (Glasgow, UK)

Question Title

* 27. For - Eric Vilain (Los Angeles, USA)

Question Title

* 28. Against - Andy Greenfield (Oxford, UK)

Question Title

* 29. Did all speakers provide their potential conflict of interest declaration with the sponsor(s) as a 2nd slide in their presentation?1 - Dont' know, 2 - No, 3 - Yes a few, 4 - Yes mostly, 5 - Yes all

Question Title

* 30. Do you agree that the information was overall free of commercial and other bias?1 - Don't know, 2 - Strongly disagree, 3 - Rather disagree, 4 - Rather agree, 5 - Strongly agree

Question Title

* 31. Social Event

Question Title

* 32. How did you rate the quality and educational value of the two oral communication sessions?1 - poor, 5 - excellent

Question Title

* 33. How do you rate the relevance of this Symposium to your need to keep informed about DSD research1 - no part relevant, 2 - little of relevance, 3 - fairly relevant, 4 - mostly relevant, 5 - highly relevant

Question Title

* 34. How did you rate the quality and educational value of the poster session?1 - poor, 5 - excellent

Question Title

* 35. What was your overall impression of this event?

Question Title

* 36. What did you like most about this event?

Question Title

* 37. What did you like least about this event?

Question Title

* 38. Are there any topics you would like to see included in future events?

Question Title

* 39. Have you any comments about the meeting in general?

* 19. Challenging case discussions in DSD
Presenters: Hedi Claahsen & Berenice Mendonca
Moderators: David Sandberg & Rodolfo Rey

* 29. Did all speakers provide their potential conflict of interest declaration with the sponsor(s) as a 2nd slide in their presentation?

1 - Dont' know, 2 - No, 3 - Yes a few, 4 - Yes mostly, 5 - Yes all

* 30. Do you agree that the information was overall free of commercial and other bias?

1 - Don't know, 2 - Strongly disagree, 3 - Rather disagree, 4 - Rather agree, 5 - Strongly agree

* 32. How did you rate the quality and educational value of the two oral communication sessions?

1 - poor, 5 - excellent

* 33. How do you rate the relevance of this Symposium to your need to keep informed about DSD research

1 - no part relevant, 2 - little of relevance, 3 - fairly relevant, 4 - mostly relevant, 5 - highly relevant

* 34. How did you rate the quality and educational value of the poster session?

1 - poor, 5 - excellent